Solvay S.A. : Solvay launches tender offer to buy-back

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
41
Solvay S.A. : Solvay launches tender offer to buy-back senior USD 400 and USD 250 million bonds

Brussels, September 21, 2017 --- Solvay has launched a cash tender offer to repurchase bonds on the following issuances:

  • Senior USD 400 million debt at 3.5%, due in 2023     (CUSIP/ISIN: 232820AJ9/US232820AJ97).
  • Senior USD 250 million debt at 3.95%, due in 2029   (CUSIP/ISIN: 232820AK6/US232820AK60).

The offer is made to eligible bondholders until September 27, 2017, on the terms and subject to the conditions further described in the following link:           https://dl.bourse.lu/dl?v=ADyMFy5zxNFitbuuk6w...T+BsB6kQ== .

This announcement does not constitute an invitation to participate in cash tender offers to repurchase the bonds mentioned herein (the "Notes", and such tender offers, the "Offers") in any jurisdiction in which, or to any person to or from whom, it is unlawful to make such invitation or for there to be such participation under applicable securities laws.  The distribution of this announcement in certain jurisdictions may be restricted by law.

The communication of this announcement and any other documents or materials relating to the Offers is not being made, and such documents and/or materials have not been approved, by an authorised person for the purposes of section 21 of the Financial Services and Markets Act 2000, as amended. Accordingly, such documents and/or materials are not being distributed to, and must not be passed on to, the general public in the United Kingdom. The communication of such documents and/or materials as a financial promotion is only being made to those persons in the United Kingdom falling within the definition of investment professionals (as defined in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "Financial Promotion Order")) or persons who are within Article 43(2) of the Financial Promotion Order or any other persons to whom it may otherwise lawfully be made under the Financial Promotion Order (such persons together being the "Relevant Persons"). The Offers are only available to Relevant Persons and the transactions contemplated in this announcement will be available only to, or engaged in only with, Relevant Persons, and this announcement and any other documents and/or materials produced in connection with the Offers must not be relied or acted upon by persons other than Relevant Persons.

The Offers are not being made, directly or indirectly, to the public in Belgium.  Neither this announcement nor any other documents or materials relating to the Offers have been submitted to or will be submitted for approval or recognition to the Belgian Financial Services and Markets Authority ( Autoriteit yoor Financiële Diensten en Markten / Financial Services and Market Authority ) and, accordingly, the Offers may not be made in Belgium by way of a public offering, as defined in Articles 3, § 1, 1° and 6 of the Belgian Law of 1 April 2007 on public takeover bids (the "Belgian Takeover Law") as amended or replaced from time to time.  Accordingly, the Offers may not be advertised and the Offers will not be extended, and neither this announcement nor any other documents or materials relating to the Offers (including any memorandum, information circular, brochure or any similar documents) has been or shall be distributed or made available, directly or indirectly, to any person in Belgium other than "qualified investors" as referred to in Article 6, § 3 of the Belgian Takeover Law and as defined in Article 10 of the Belgian Law of 16 June 2006 on the public offer of investment instruments and the admission to trading of investment instruments on a regulated market (as amended from time to time), acting on their own account.  Insofar as Belgium is concerned, this announcement have been issued only for the personal use of the above qualified investors and exclusively for the purpose of the Offers. Accordingly, the information contained in this announcement may not be used for any other purpose or disclosed to any other person in Belgium.

The Offers are not being made, directly or indirectly, to the public in the Republic of France ("France").  Neither this announcement nor any other documents or materials relating to the Offers have been or shall be distributed to the public in France and only (i) providers of investment services relating to portfolio management for the account of third parties ( personnes fournissant le service d'investissement de gestion de portefeuille pour compte de tiers ) and/or (ii) qualified investors ( investisseurs qualifiés ) other than individuals, acting on their own account and all as defined in, and in accordance with, Articles L.411-1, L.411-2 and D.411-1 of the French Code Monétaire et Financier , are eligible to participate in the Offers.  This announcement and any other document or material relating to the Offers have not been and will not be submitted for clearance to nor approved by the Autorité des marchés financiers .

None of the Offers, this announcement or any other documents or materials relating to the Offers have been or will be submitted to the clearance procedure of the Commissione Nazionale per le Società e la Borsa ("CONSOB"). The Offers are being carried out in the Republic of Italy as exempted offers pursuant to article 101-bis, paragraph 3-bis of the Legislative Decree No. 58 of 24 February 1998, as amended (the "Financial Services Act") and article 35-bis, paragraph 4 of CONSOB Regulation No. 11971 of 14 May 1999, as amended. Noteholders, or beneficial owners of the Notes, can tender some or all of their Notes pursuant to the Offers through authorised persons (such as investment firms, banks or financial intermediaries permitted to conduct such activities in Italy in accordance with the Financial Services Act, CONSOB Regulation No. 16190 of 29 October 2007, as amended from time to time, and Legislative Decree No. 385 of September 1, 1993, as amended) and in compliance with applicable laws and regulations or with requirements imposed by CONSOB or any other Italian authority. Each intermediary must comply with the applicable laws and regulations concerning information duties vis-à-vis its clients in connection with the Notes or the Offers.

Neither this announcement nor the electronic transmission thereof constitutes an offer to buy or the solicitation of an offer to sell Notes (and tenders of Notes for purchase pursuant to the Offers will not be accepted from Noteholders) in any circumstances in which such offer or solicitation is unlawful.

       Follow us on twitter @SolvayGroup

Solvay is a multi-specialty chemical company, committed to developing chemistry that addresses key societal challenges. Solvay innovates and partners with customers in diverse global end markets. Its products and solutions are used in planes, cars, smart and medical devices, batteries, in mineral and oil extraction, among many other applications promoting sustainability. Its lightweighting materials enhance cleaner mobility, its formulations optimize the use of resources and its performance chemicals improve air and water quality. Solvay is headquartered in Brussels with around 27,000 employees in 58 countries. Net sales were € 10.9 billion in 2016, with 90% from activities where Solvay ranks among the world's top 3 leaders. Solvay SA ( SOLB.BE ) is listed on Euronext Brussels and Paris (Bloomberg:  SOLB.BB  - Reuters:  SOLB.BR ) and in the United States its shares (SOLVY) are traded through a level-1 ADR program.
Caroline Jacobs Kimberly Stewart Jodi Allen Geoffroy Raskin Bisser Alexandrov
Media Relations Investor Relations Investor Relations Investor Relations Investor Relations
+32 2 264 1530 +32 2 264 3694 +1 973 357 3283 +32 2 264 1540 +32 2 264 3687
Attachments:

http://www.globenewswire.com/NewsRoom/Attachm...3b47bd7ee5

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Workhorse Group Battles Nasdaq Compliance Amid Financial Woes

Updated Category News Views 87

Workhorse Group Faces Nasdaq Compliance Challenges Workhorse Group Inc (NASDAQ: WKHS), a manufacturer in the electric vehicle sector, has recently been issued a notice by the Nasdaq Stock Market regarding its non-compliance with the minimum bid price requirement. The pressing issue arises from the company's common stock trading below the $1.00 mark for a continuous period...

Continue Reading
Investors Have a Deadline to Join NET Power Class Action

Updated Category News Views 293

Investors Have a Deadline to Join NET Power Class Action In a significant turn of events, Kahn Swick & Foti, LLC advises investors who’ve incurred losses exceeding $100,000 in NET Power Inc. to take action. If you are among those affected, the time is critical. You have until June 17, 2025 to file your lead plaintiff application in this securities class action lawsuit...

Continue Reading
New Developments in Borregaard ASA's Share Transactions

Updated Category News Views 152

Insight into Recent Share Purchases at Borregaard ASA Recently, significant transactions have emerged within Borregaard ASA that are noteworthy for investors and stakeholders alike. Tove Andersen, a dedicated member of the board, made headlines by acquiring 2,000 shares at a price of NOK 187.92 each. This purchase marks a decisive move, increasing her total holdings to...

Continue Reading
Guaranteed Roof Enhances Commercial Roofing Options in NC

Updated Category News Views 136

Guaranteed Roof Enhances Commercial Roofing Options in North Carolina Guaranteed Roof, recognized for its expertise in roof rejuvenation and replacement services, is excited to announce a major enhancement to its commercial division. This initiative strongly emphasizes the utilization of FAR Coatings, a cutting-edge solution for flat and low-slope roofs. By leveraging...

Continue Reading
Key Details for Sage Therapeutics, Inc. Investors Ahead of Deadline

Updated Category News Views 38

Understanding the Class Action for Sage Therapeutics, Inc. As a diligent investor, knowing your rights is crucial, especially when involved with companies like Sage Therapeutics, Inc. (NASDAQ: SAGE). If you purchased securities between specific dates, it’s essential to pay attention to upcoming deadlines. The Importance of the Deadline The Rosen Law Firm, a leading...

Continue Reading